Enabling better health outcomes from infectious diseases through rapid diagnostics
Rapid Infection Diagnostics (RID) Inc. was founded in August of 2019 with a mission of reducing death and disability from infectious diseases via state-of-the-art diagnostic technology.
RID Inc. leverages advanced mass spectrometry to enable a suite of rapid diagnostic tests that reduce microbiology testing times from days to hours.
Mission
Enable better health outcomes from infectious diseases through rapid diagnostics.
Key Value Proposition
RID Inc. technology enables the fastest and most comprehensive microbiology testing workflow
Team + Partners
Meet the partners and team behind RID Inc.
Technology
Our team has developed Hopper™, a rapid, high throughput metabolomics-based platform for identification (ID) and antibiotic susceptibility testing (AST) of microbes on a single platform. You can also view our existing patents here.
“The impact of RID Inc. technologies will be measured in thousands of lives and millions of dollars saved annually”
— Dr. Ian Lewis
Stay in touch.
Join our distribution list and be the first to know about any major announcements from RID Inc.